91929 ⎘
Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups; Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups Citric acid
SALTS AND SOLID FORMS OF (S)- OR RACEMIC 3-(4-((4-(MORPHOLINOMETHYL)BENZYL)OXY)-1-OXOISOINDOLIN-2-YL)PIPERIDINE-2,6-DIONE AND METHODS OF USING THE SAME
#2Psilocin crystalline forms
#3Composition and Method for Treating Metabolic Disorders
#4COMPOSITIONS PROVIDING SLOW RELEASE OF CAFFEINE
#5PHARMACEUTICALLY ACCEPTABLE SALT AND CRYSTAL FORM OF NITROGEN-CONTAINING BRIDGE HETEROCYCLIC DERIVATIVE, AND METHOD FOR PREPARING SAME
#6CRYSTALLINE FORMS AND SALTS OF A MUSCARINIC RECEPTOR AGONIST
#7CRYSTALLINE FORMS AND SALTS OF A PI3K INHIBITOR AND METHODS OF MAKING AND METHODS OF USE THEREOF
#8SOLID FORMS OF A TRIAZINE DERIVATIVE AS CBL-B MODULATOR
#9SALT CRYSTAL FORM AND FREE BASE CRYSTAL FORM OF KINASE INHIBITOR
#10POLYMORPHIC AND SALT FORMS OF (1S,3S)-N1-(5-(PENTAN-3-YL)PYRAZOLO[1,5-A]PYRIMIDIN-7-YL) CYCLOPENTANE-1,3-DIAMINE
#11CRYSTAL FORM OF BLARCAMESINE HYDROCHLORIDE, METHOD FOR PREPARING SAME, AND USE THEROF
#12CRYSTALLINE FORMS OF A PAR4 INHIBITOR
#13R-KETAMINE SALTS AND METHODS OF USE THEREOF
#14CO-CRYSTAL OF CITRIC ACID AND GLYCINE AND USES THEREOF
#15SYNTHESIS AND NOVEL SALT FORMS OF (R)-5-((E)-2-(PYRROLIDIN-3-YLVINYL)PYRIMIDINE
#16SYNTHESIS AND NOVEL SALT FORMS OF (R)-5-((E)-2-PYRROLIDIN-3-YLVINYL)PYRIMIDINE
#17Composition and Method for Treating Metabolic Disorders
#18Facile Synthesis of Aluminum Salts Using Activated Aluminum Precursor
#19Composition and Method for Treating Metabolic Disorders
#205-HT3 RECEPTOR MODULATOR, THE CRYSTALLINE FORM, METHODS OF MAKING, AND USE THEREOF
#21COMPOSITIONS PROVIDING SLOW RELEASE OF CAFFEINE
#22Ferric Organic Compounds, Uses Thereof and Methods of Making Same
#23Hydroxycitric acid metal heterocyclic compounds with covalent characteristics
#24Pharmaceutical-Grade Ferric Organic Compounds, Uses Thereof and Methods of Making Same
#25Crystalline forms of a PAR4 inhibitor
#26NOVEL SALTS AND POLYMORPHS OF SCY-078
#27Synthesis and novel salt forms of (R)-5-((E)-2-pyrrolidin-3-ylvinyl)pyrimidine
#28PHARMACEUTICAL-GRADE FERRIC ORGANIC COMPOUNDS, USES THEREOF AND METHODS OF MAKING SAME
#29Zuclomiphene salts and crystalline forms thereof
#30Composition and method for treating metabolic disorders
#31Compositions and methods to improve exercise performance and recovery
#32IRON AMINO ACID COMPOUNDS, METHOD FOR PREPARING IRON AMINO ACID COMPOUNDS, COMPOSITIONS CONTAINING IRON AMINO ACID COMPOUNDS, AND USES THEREOF
#33Hydroxycitric acid metal heterocyclic compounds with covalent characteristics
#34Composition and method for treating metabolic disorders
#35Synthetic nicotine composition
#36IRON (III) CITRATE, SUBSTANTIALLY FREE OF BETA-IRON HYDROXIDE OXIDE
#37NOVEL CRYSTALLINE FORMS OF TAMIBAROTENE FOR TREATMENT OF CANCER
#38Synthesis and novel salt forms of (R)-5-((E)-2-pyrrolidin-3-ylvinyl)pyrimidine
#39Compounds for bone growth
#40Salts and polymorphs of SCY-078
#41Salt of quinazoline derivative, preparation method therefor and application thereof
#42PHARMACEUTICAL-GRADE FERRIC ORGANIC COMPOUNDS, USES THEREOF AND METHODS OF MAKING SAME
#43Cerium citrate, method of making and corrosion inhibitor comprising cerium citrate
#44Salts and crystal forms of diaza-benzofluoranthrene compounds
#45Salts and polymorphs of SCY-078
#46Salt forms of (R)-5-((E)-2-pyrrolidin-3-ylvinyl)pyrimidine
#47FERRIC ORGANIC COMPOUNDS, USES THEREOF AND METHODS OF MAKING SAME
#48Method for the synthesis of ferric oraganic compounds
#49Iron amino acid compounds, method for preparing iron amino acid compounds, compositions containing iron amino acid compounds, and uses thereof
#50Process for the preparation of enclomiphene citrate having needle shaped crystal habit
#51Co-crystals and pharmaceutical compositions comprising the same
#52Separating carboxylic acids
#53FORMS AND COMPOSITIONS OF BIARYL INHIBITORS OF BRUTON'S TYROSINE KINASE
#54Process for the Preparation of Pharmaceutical Grade Ferric Citrate
#55PHARMACEUTICAL-GRADE FERRIC ORGANIC COMPOUNDS, USES THEREOF AND METHODS OF MAKING SAME
#56CHELATING AGENT AND PREPARATION METHOD AND USE THEREOF
#57Compositions and methods to improve exercise performance and recovery
#58Plasticizer composition, resin composition, and preparation methods therefor
#59Process for purification of an organic acid including an electrodialysis treatment step
#60Composition and method for treating metabolic disorders
#614-AZIDOBUTYLAMINES AND PROCESSES FOR PREPARING
#62IRON (III) CITRATE, SUBSTANTIALLY FREE OF BETA-IRON HYDROXIDE OXIDE
#63Cerium citrate, method of making and corrosion inhibitor comprising cerium citrate
#64STABLE SOLID FORMS OF ENCLOMIPHENE AND ENCLOMIPHENE CITRATE
#65Composition and Method for Treating Metabolic Disorders
#66Compounds for bone growth
#67CARBAMATE/UREA DERIVATIVES
#68Synthesis and novel salt forms of (R)-5-((E)-2-pyrrolidin-3-ylvinyl)pyrimidine
#69ALKALINE EARTH METAL SALTS
#70Cocrystal, production method thereof, and medicament containing cocrystal
#71Co-crystal of dapagliflozin with citric acid
#72Process for the preparation of vortioxetine salts
#73AZIDOALKYLAMINE SALTS AND THEIR USE AS INTERMEDIATES
#74NON-HYGROSCOPIC SALTS OF 5-HT2C AGONISTS
#75Clomiphene synthesis using a single solvent
#76Stable solid forms of enclomiphene and enclomiphene citrate
#77Co-crystals and pharmaceutical compositions comprising the same
#78Particles of N-(5-cyano-4-((2-methoxyethyl)amino)pyridin-2-yl)-7-formyl-6-((4-methyl-2-oxopiperazin-1-yl)methyl)-3,4-dihydro-1,8-naphthyridine-1(2H)-carboxamide
#79Aryl naphthyl methanone oxime(s) and process for preparation thereof
#80Metal complexes and methods of treatment
#81Carbamate/urea derivatives
#82Inhibitors of histone demethylases
#83Salts and polymorphs of SCY-078
#84Method for preparing benzamide derivative, novel intermediate used in preparation of benzamide, and method for preparing novel intermediate
#85PROCESS FOR THE PREPARATION OF (3R,4R)-4-METHYL-3-(METHYL-7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL-AMINO)-ß-OXO-1-PIPERIDINEPROPANENITRILE AND ITS SALTS
#86Pharmaceutical-grade ferric organic compounds, uses thereof and methods of making same
#87SYNTHESIS AND NOVEL SALT FORMS OF (R)-5-((E)-2-PYRROLIDIN-3YLVINYL)PYRIMIDINE
#88Process or preparing spirocyclic cyclohexane compounds, compositions containing such compounds and method of using such compounds
#89Carbamate/urea derivatives
#90Crystalline forms of a purine derivative
#91Iron (III) citrate, substantially free of beta-iron hydroxide oxide
#92Surface-treated carbon nanotube and resin composition
#93Pharmaceutical-grade ferric organic compounds, uses thereof and methods of making same
#94Compounds for bone growth
#95ACID ADDITION SALTS OF BOSENTAN
#96ACID ADDITION SALTS OF 5ALPHA-HYDROXY-6BETA-[2-(1H-IMIDAZOL-4-YL)ETHYLAMINO]CHOLESTAN-3BETA-OL
#97Carbamate/urea derivatives
#98Synthesis and novel salt forms of (R)-5-((E)-2-pyrrolidin-3ylvinyl)pyrimidine
#99Pharmaceutically acceptable cocrystals of N-[2-(7-methoxyl-1-naphtyl)ethyl]acetamide and methods of their preparation
#100Ferric organic compounds, uses thereof and methods of making same
#101Ferric organic compounds, uses thereof and methods of making same
#102Ferric organic compounds, uses thereof and methods of making same
#103Salts of kukoamine B, preparation method and use thereof
#104Aildenafil citrate crystal form O, preparation method and use thereof
#105Compound for inhibiting type 5 phosphodiesterase and preparation method thereof
#106Crystalline forms of a purine derivative
#107Pharmaceutical-grade ferric organic compounds, uses thereof and methods of making same
#108Co-crystals of agomelatine, a process for there preparation and pharmaceutical compositions containing them
#109DELAYED RELEASE RASAGILINE FORMULATION
#110Addition compounds of guanidinoacetic acid
#111IRON (III) CITRATE, SUBSTANTIALLY FREE OF BETA-IRON HYDROXIDE OXIDE
#112POLYMORPHIC FORM OF TOREMIFENE CITRATE AND PROCESS FOR ITS PREPARATION
#113Co-precipitated salts of fatty acids
#114Pharmaceutical-grade ferric organic compounds, uses thereof and method of making same
#115RECOVERY OF ORGANIC ACIDS
#116DELAYED RELEASE RASAGILINE MALATE FORMULATION
#117Salts or co-crystals of 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)-phenol
#118DELAYED RELEASE RASAGILINE FORMULATION
#119Process for preparing spirocyclic cyclohexane compounds, compositions containing such compounds and method of using such compounds
#120Co-precipitated salts of fatty acids
#121Gaseous ammonia removal system
#122Method for the production of free carboxylic acids
#123SOLID STATES OF O-DESMETHYLVENLAFAXINE SALTS
#124SOLID FORMS OF TENOFOVIR DISOPROXIL
#125Spirocyclic cyclohexane compounds
#126Ferric organic compounds, uses thereof and methods of making same
#127Citrate salt of Rasagiline
#128Delayed release rasagiline malate formulation
#129Delayed release rasagiline formulation
#130Delayed release rasagiline base formulation
#131Delayed release rasagiline citrate formulation
#132Recovery of organic acids
#133Dual cation dual anion coordination complexes
#134CARBOXYLIC ACIDS PREPARED USING A SALT-SPLITTING PROCESS
#135Method for depletion of sulfur and/or compounds containing sulfur from a biochemically produced organic compound
#136Water-based rare earth metal compound sol, manufacturing method thereof, and method for manufacturing ceramic powder using the same
#137Recovery of organic acids
#138ORGANIC ACID CHROMIUM (III) SALT AQUEOUS SOLUTION AND PROCESS OF PRODUCING THE SAME
#139Spirocyclic cyclohexane compounds
#140Compositions containing spirocyclic cyclohexane compounds
#141PROCESS FOR PREPARING CONCENTRATED SOLUTIONS OF SALTS OF ORGANIC ACIDS
#142Methods and compositions for phosphate binding
#143Novel Isovaleramide Forms, Compositions Thereof, and Related Methods of Use
#144Pharmaceutical-grade ferric organic compounds, uses thereof and method of making same
#145Novel manufacturing process for milk acid
#146Acetyl L-Carnitine For Preventing Painful Peripheral Diabetic Neuropathy
#147PROCESS FOR THE RECOVERY OF CITRIC ACID
#148Compositions comprising calcium citrate malate and methods for making the same
#149Compositions comprising calcium citrate malate and methods for making the same
#150Crystal of L-Ornithine-Citric Acid Salt
#151Highly soluble form of tricalcium citrate, and methods of its making and use
#152Amorphous water-soluble calcium citrate salts and method of making and using same
#153Separation of citric acid from gluconic acid in fermentation broth using a weakly or strongly basic anionic exchange resin adsorbent
#154Process for recovering organic compounds from aqueous streams containing same
#155Organic acid anion containing aluminum salt hydroxide particles, production method thereof, and use thereof
#156Anhydrous silver dihydrogen citrate compositions
#157Method of manufacturing a granular mineral composition
#158HFC SOLUTION FORMULATIONS CONTAINING SALBUTAMOL HYDROCHLORIDE OR SALBUTAMOL CITRATE
#159Rare earth metal compound in aqueous solvent, method for producing same, and method for producing ceramic powder using same
#160Meldonium salts, method of their preparation and pharmaceutical composition on their basis
#161Process for the recovery of citric acid
#162Anhydrous silver dihydrogen citrate compositions
#163Purifying polyoxyethylated castor oils with activated charcoal and pharmaceutical formulations thereof
#164Ferric organic compounds, uses thereof and methods of making same
#165Spirocyclic cyclohexane compounds
#166Highly soluble form of tricalcium citrate, and methods of its making and use
#167Recovery of organic acids
#168Anhydrous silver dihydrogen citrate compositions
#169Silver dihydrogen citrate compositions comprising a second antimicrobial agent
#170Dietary supplementation with stoichiometrically specific potassium magnesium citrate
#171Amorphous water-soluble calcium citrate salts and method of making and using same
#172Method of making salt
#173Pharmaceutical-grade ferric citrate
#174Process for treating a liquid